Webinar – Removing and Destroying Airborne Pathogens in Homes
Guest Speaker: Dr. Mark Ereth, Emeritus Professor of Anesthesiology, Mayo Clinic College of Medicine
We now know that some harmful pathogens are spread from one to another by touch, while others can be spread by inhalation. The SARS-CoV-2 virus that is responsible for the COVID-19 pandemic is spread primarily by respiratory droplets. These droplets are produced when coughing, sneezing, and it was just confirmed that the virus can be spread with just normal breathing.
As an HVAC contractor, you can be the best source for the most effective whole-home remedy to the health-threatening challenge we are now facing. Your customers expect you, as someone they trust, to provide accurate information about the technologies that various IAQ products use, how effective they can be, and if there are any concerns when using them in the home.
Join us and learn more from Dr. Mark Ereth about the differences among the airborne pathogens, including bacteria and viruses, and what recent studies have shown about the challenges of removing and destroying them from the air that we breathe. He will also discuss the dangers of breathing all small airborne particulates and other airborne chemical compounds, and how absorbing them can cause damage to virtually every organ in the body.
Our discussions will include data from the EPA booklet, Residential Air Cleaners a Technical Summary, that provides us with an unbiased comparison of all IAQ technologies.
This webinar was delivered on a Zoom platform, Apr 9, 2020 12:30 PM Central Time (US and Canada).
Mark Ereth, MD, Emeritus Professor of Anesthesiology, Mayo Clinic College of Medicine, Co-Founder and CEO, APRI Health, Inc.
Dr. Ereth is an internationally known expert in anesthesiology, transfusion, platelet function, and blood management who is a frequent speaker at medical schools and hospitals around the world. Dr. Ereth’s career has been marked by innovation and collaboration. In his 25 years at the Mayo Clinic he provided anesthesia and critical care to over 10,000 patients and authored more than one hundred peer reviewed journal articles and abstracts. He holds multiple patents for medical devices and upon retirement from the Mayo Clinic he founded Apri Health, Inc., where his team focuses on novel analytic solutions to common problems of patient safety and over-utilization. Mark also co-founded Cheetah Development, a non-profit based on a novel method of funding, Micro-Venture Capital.
